Intracranial Pressure Monitoring Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technique (Invasive, Non-invasive), By Application (Traumatic Brain Injury, Intracerebral Hemorrhage, Meningitis, Subarachnoid Hemorrhage, CSF Management, Migraine, Stroke, Hydrocephalus, EEG, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 1.93 Billion
CAGR (2026-2031)	8.56%
Fastest Growing Segment	Meningitis
Largest Market	North America
Market Size (2031)	USD 3.16 Billion

Market Overview

The Global Intracranial Pressure Monitoring Devices Market is projected to grow from USD 1.93 Billion in 2025 to USD 3.16 Billion by 2031 at a 8.56% CAGR. Intracranial pressure monitoring devices are diagnostic medical instruments designed to measure the pressure inside the skull, providing critical data for the management of severe traumatic brain injuries and other neurological conditions. The market is primarily driven by the rising global incidence of head trauma and the increasing prevalence of neurodegenerative disorders, which necessitate precise monitoring to prevent secondary brain damage. Furthermore, the expanding geriatric population, who are more susceptible to falls and subsequent cranial injuries, significantly supports the demand for these interventions. According to the World Health Organization, in 2024, neurological conditions affected more than one in three people globally, making them the leading cause of illness and disability worldwide.

Despite the strong clinical demand, the market faces a significant challenge regarding the high cost of implementation and the risks associated with invasive monitoring procedures. The potential for procedural complications, such as hemorrhages or infections, often deters widespread adoption, particularly in healthcare settings with limited resources or infrastructure. Additionally, the substantial expense linked to the devices and the required hospital stays can restrict access in developing regions, potentially impeding the overall expansion of the global market.

Key Market Drivers

The increasing prevalence of cerebrovascular diseases and stroke is a primary catalyst for the global intracranial pressure monitoring devices market. Stroke, particularly hemorrhagic variants, frequently results in elevated intracranial pressure, necessitating continuous monitoring to manage cerebral perfusion and prevent secondary brain injury. This escalating clinical burden creates a substantial volume of patients requiring critical care intervention, directly fueling the adoption of monitoring technologies. According to the World Stroke Organization, in the 'Global Stroke Fact Sheet 2025', there were approximately 11.9 million new stroke cases globally in 2021, a figure that underscores the urgent and growing need for effective neurological management solutions. This high incidence rate translates into tangible market performance for established device manufacturers; for instance, according to Integra LifeSciences, in February 2025, the company reported that its neuro monitoring segment grew high single-digits, driven significantly by the demand for its CereLink intracranial pressure monitors.

Technological innovations in non-invasive monitoring modalities are simultaneously expanding the market by addressing the risks associated with traditional invasive procedures. Standard methods, such as external ventricular drains, carry inherent risks of infection and hemorrhage, which often restrict their application to only the most severe cases. However, next-generation non-invasive technologies utilize advanced sensors and algorithms to estimate pressure without surgical penetration, thereby broadening patient access and enabling earlier intervention in diverse healthcare settings. This shift toward safer diagnostics is exemplified by recent industry breakthroughs. According to NeuroNews International, in December 2025, Sonobrain Diagnostics secured the SVINnovation prize for its fully automated, non-invasive head-mounted device designed to measure optic nerve sheath diameter as a reliable surrogate for intracranial pressure. Such advancements are poised to democratize access to critical monitoring, particularly in regions with limited neurosurgical infrastructure.

Download Free Sample Report

Key Market Challenges

The growth of the Global Intracranial Pressure Monitoring Devices Market is significantly hampered by the high costs and clinical risks inherent to invasive monitoring procedures. These devices typically require surgical insertion, exposing patients to serious complications such as hemorrhages, tissue damage, and central nervous system infections. Consequently, the adoption of these critical tools is often restricted to specialized neurocritical care units with the infrastructure to manage such risks, limiting their utility in general healthcare settings where surgical expertise may be scarce.

Financial constraints further compound this issue, as the substantial expense of the devices and associated hospitalization creates a barrier to entry. Healthcare systems facing budget deficits often prioritize essential care over expensive diagnostic technologies. According to the United Kingdom Acquired Brain Injury Forum, in 2025, the total economic impact of acquired brain injuries reached £43 billion annually in the UK, a financial burden that significantly restricts available capital for procuring advanced monitoring instrumentation. This economic pressure forces hospitals to rely on less invasive, though potentially less accurate, alternatives, directly reducing the market share for invasive intracranial pressure monitoring solutions.

Key Market Trends

The integration of AI-driven predictive analytics is fundamentally reshaping the market by transitioning clinical focus from reactive measurement to proactive risk management. Advanced algorithms are now being deployed to aggregate continuous intracranial pressure data with disparate physiological markers, enabling the early prediction of hypertensive events and secondary brain injury. This technological leap is attracting targeted capital investment aimed at accelerating the commercialization of intelligent clinical decision support systems. For instance, according to Moberg Analytics, October 2025, in the press release 'Moberg Analytics Secures Funding for Brain Monitoring Platform', the company secured $600,000 in seed capital to expedite the market launch of its AI-based multimodal solution designed to revolutionize patient data integration in neurocritical care settings.

Simultaneously, there is a decisive shift toward multimodal neuromonitoring systems that consolidate intracranial pressure readings with neuro-navigation, imaging, and external physiological data into unified digital ecosystems. This trend addresses the increasing complexity of neurological procedures by providing surgeons with a comprehensive, real-time view of brain health, thereby driving the adoption of integrated platforms over standalone monitoring devices. The market impact of this consolidation is evident in the performance of major industry players; according to Medtronic, February 2025, in the 'Third Quarter Fiscal 2025 Financial Results', the company’s neurosurgery division reported high single-digit revenue growth, a performance attributed significantly to the continued adoption of its AiBLE ecosystem which integrates enabling technologies for complex cranial procedures.

Segmental Insights

Based on recent market research, the Meningitis segment is emerging as the fastest-growing application area in the Global Intracranial Pressure Monitoring Devices Market. This rapid expansion is primarily driven by the rising global incidence of acute bacterial and viral meningitis, which often result in severe intracranial hypertension due to cerebral edema. Healthcare providers are increasingly prioritizing continuous pressure monitoring to manage therapeutic interventions and prevent life-threatening complications such as brain herniation. Consequently, the critical clinical need for precise, real-time data to guide treatment protocols in neurocritical care settings is fueling the substantial demand for monitoring devices within this segment.

Regional Insights

North America maintains a leading position in the global intracranial pressure monitoring devices market, driven by a high incidence of traumatic brain injuries and neurological disorders. The region possesses a developed healthcare infrastructure that supports the adoption of medical technologies. Additionally, the presence of major manufacturers and favorable reimbursement policies contributes to market expansion. The U.S. Food and Drug Administration plays a critical role by maintaining clear pathways for product approvals, ensuring that safe devices reach the market efficiently. These factors collectively solidify North America’s dominance in this sector.

Recent Developments

• In November 2024, Sense Neuro Diagnostics announced that it had been awarded a $2 million contract by the Department of Defense to advance its brain hemorrhage detection technology. The funding was allocated to support clinical trials for the company's NeuroHawk device, which is designed to detect hemorrhage in specific brain regions and provide rapid diagnosis of traumatic brain injury. The CEO of Sense Neuro Diagnostics highlighted that the device aims to offer critical insights in high-pressure environments, such as field conditions, by non-invasively localizing brain bleeding and monitoring patients for stroke and injury.
• In August 2024, Aesculap, Inc., in partnership with Christoph Miethke GmbH & Co. KG, announced that the U.S. Food and Drug Administration had granted Breakthrough Device Designation for the M.scio System. This non-invasive, telemetric pressure measurement system was designed to provide continuous, long-term monitoring of intracranial pressure for patients with hydrocephalus using a fully implantable sensor. The Corporate Vice President of Aesculap noted that the designation recognized the device's potential to offer a more effective treatment option than current modalities, aiming to improve patient management and outcomes through innovative technology.
• In July 2024, Braincare Desenvolvimento e Inovacao Tecnologica S.A. received FDA 510(k) clearance for its B4C System equipped with a new piezoelectric sensor model. The system is a non-invasive device designed to monitor variations in intracranial pressure and compliance by analyzing surrogate waveforms and associated parameters. This regulatory milestone allowed the company to market the device for adult patients with suspected intracranial pressure alterations. The clearance confirmed that the new sensor technology was substantially equivalent to existing methods, offering a wireless solution for acquiring and processing physiological data in clinical settings.
• In April 2024, Integra LifeSciences Holdings Corporation announced that its CereLink Intracranial Pressure Monitoring System would be featured at the American Association of Neurological Surgeons Annual Scientific Meeting in Chicago. This showcase followed the company's successful relaunch of the device in the United States earlier in the year. The system provides clinicians with advanced continuous pressure monitoring capabilities, featuring durable sensors with minimal drift and MR conditional utility. The Executive Vice President of Codman Specialty Surgical stated that the relaunch addressed a critical need for accurate monitoring in patients managing traumatic brain injuries, intracranial hemorrhages, and other serious neurological conditions.

Key Market Players

• Medtronic plc
• Integra LifeSciences Holdings Corporation
• Raumedic AG
• Natus Medical Incorporated
• Spiegelberg GmbH & Co. KG
• Sophysa SA
• Gaeltec Devices Ltd.
• Orsan Medical Technologies Ltd.
• Biometrix Ltd.
• Third Eye Diagnostics Inc.

By Technique	By Application	By Region
Invasive Non-invasive	Traumatic Brain Injury Intracerebral Hemorrhage Meningitis Subarachnoid Hemorrhage CSF Management Migraine Stroke Hydrocephalus EEG Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Intracranial Pressure Monitoring Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Intracranial Pressure Monitoring Devices Market, By Technique:

• Invasive
• Non-invasive

• Intracranial Pressure Monitoring Devices Market, By Application:

• Traumatic Brain Injury
• Intracerebral Hemorrhage
• Meningitis
• Subarachnoid Hemorrhage
• CSF Management
• Migraine
• Stroke
• Hydrocephalus
• EEG
• Others

• Intracranial Pressure Monitoring Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE